Experiences with
Jemperli

4 public posts

JEMPERLI (dostarlimab), a new programmed death receptor-1 (PD-1)-blocking antibody

It is called Jemperli (dostarlimab-gxly) and offered by GlaxoSmithKline (GSK).

It is called Jemperli (dostarlimab-gxly) and offered by GlaxoSmithKline (GSK).

in Advanced Prostate Cancer

2 years ago

Dostarlimab for Liver Cancer?

Has anyone heard of Dostarlimab (Jemperli) being used to address liver cancer? This drug has received some attention recently as a very effective cancer treatment.

Has anyone heard of Dostarlimab (Jemperli) being used to address liver cancer? This drug has received some attention recently as a very effective cancer treatment.

in British Liver Trust

2 years ago

CANCER REMISSION: Trial Using Monoclonal Antibody Finds Remission in Every Patient: New England Journal of Medicine

However, after taking dostarlimab, which is sold under the brand name Jemperli, no cases of progression or recurrence were reported in the patients who underwent the study. Dostarlimab is already approved by the U.S.

However, after taking dostarlimab, which is sold under the brand name Jemperli, no cases of progression or recurrence were reported in the patients who underwent the study. Dostarlimab is already approved by the U.S.

in Advanced Prostate Cancer

2 years ago

Want to take advantage of all our features? Just log in!

or

Dostarlimab shows efficacy as curative-intent treatment in rectal cancer subset

"Thus, our hypothesis was that PD-1 blockade with dostarlimab [Jemperli, GlaxoSmithKline] could replace chemotherapy and potentially eliminate the need for radiation and surgery in these patients.”

"Thus, our hypothesis was that PD-1 blockade with dostarlimab [Jemperli, GlaxoSmithKline] could replace chemotherapy and potentially eliminate the need for radiation and surgery in these patients.”

in Advanced Prostate Cancer

2 years ago